| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $378K | +16.0% | +18.2% |
| SG&A Expense | $363K | -1.8% | -26.4% |
| Operating Income | -$741K | -6.5% | +8.9% |
| Net Income | -$712K | -7.9% | +2.6% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.0M | -20.4% | -53.3% |
| Current Assets | $3.1M | -20.0% | -52.5% |
| Total Assets | $3.1M | -19.8% | -51.4% |
| Current Liabilities | $88K | -37.5% | +96.4% |
| Long-term Debt | $44K | -15.1% | — |
| Total Liabilities | $3.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.6M | — | — |
| -1.9% |
| +2.9% |
| Stockholders' Equity | $3K | -99.5% | -99.9% |